Kassandra Johns, APRN
Family · Overland Park, KSNPI 1649037409
Payments from drug & device makers
Across 84 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$225
- Boehringer Ingelheim$133
- Lilly USA, LLC$130
- AstraZeneca$119
- AbbVie$92
- Pfizer$78
- plus $733 from 22 others
What the payments were for
- Food & beverage$1,510100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $225 |
| Boehringer Ingelheim | 6 | $133 |
| Lilly USA, LLC | 6 | $130 |
| AstraZeneca | 7 | $119 |
| AbbVie | 5 | $92 |
| Pfizer | 5 | $78 |
| Axsome Therapeutics, Inc. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 4 | $61 |
| Amgen | 4 | $60 |
| GSK | 3 | $58 |
| Boston Scientific | 2 | $52 |
| Exact Sciences | 2 | $31 |
| Viatris Specialty LLC | 2 | $30 |
| Astellas Pharma US Inc | 2 | $29 |
| Electromed, Inc. | 2 | $29 |
| Merck | 2 | $28 |
| Genentech USA, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $23 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $23 |
| Grifols USA, LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Philips North America LLC | 1 | $21 |
| EMD Serono, Inc. | 1 | $17 |
| UCB, Inc. | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $10 |
How this compares
$1,510 in reported general payments places this provider in the 80th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $756 |
| Doxycycline Hyclate | 43 | $402 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 42 | $343 |
| Methylprednisolone | 52 | $333 |
| Fluticasone Propionate | 26 | $226 |
| Naproxen | 22 | $159 |
| Cephalexin | 33 | $146 |
| Azithromycin | 21 | $74 |
| Alprazolam | 12 | $43 |
| Triamcinolone Acetonide | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Kathryn TimmOverland Park$14K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Gretchen PolandOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.